Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia

Schizophrenia Research
Francesca M NotarangeloR Schwarcz

Abstract

Toxoplasma gondii, an intracellular protozoan parasite, is a major cause of opportunistic infectious disease affecting the brain and has been linked to an increased incidence of schizophrenia. In murine hosts, infection with T. gondii stimulates tryptophan degradation along the kynurenine pathway (KP), which contains several neuroactive metabolites, including 3-hydroxykynurenine (3-HK), quinolinic acid (QUIN) and kynurenic acid (KYNA). As these endogenous compounds may provide a mechanistic connection between T. gondii and the pathophysiology of schizophrenia, we measured KP metabolites in both the brain and periphery of T. gondii-treated C57BL/6 mice 8 and 28 days post-infection. Infected mice showed early decreases in the levels of tryptophan in the brain and serum, but not in the liver. These reductions were associated with elevated levels of kynurenine, KYNA, 3-HK and QUIN in the brain. In quantitative terms, the most significant increases in these KP metabolites were observed in the brain at 28 days post-infection. Notably, the anti-parasitic drugs pyrimethamine and sulfadiazine, a standard treatment of toxoplasmosis, significantly reduced 3-HK and KYNA levels in the brain of infected mice when applied between 28 and 56 da...Continue Reading

References

Sep 1, 1992·Italian Journal of Neurological Sciences·A AntinoriE Tamburrini
May 16, 1974·The New England Journal of Medicine·G Desmonts, J Couvreur
Dec 1, 1994·Journal of Interferon Research·W DaiJ P Dubey
Dec 1, 1996·The Biochemical Journal·M P HeyesS P Markey
Nov 1, 1996·Clinical Therapeutics·H B Fung, H L Kirschenbaum
Jan 20, 1997·Neuroreport·M G EspeyC A Colton
Aug 25, 2001·Journal of Neurochemistry·G J GuilleminB J Brew
Oct 16, 2001·Biological Psychiatry·R SchwarczR C Roberts
Mar 28, 1953·British Medical Journal·J BURKINSHAWA SORSBY
Apr 6, 2004·International Journal for Parasitology·Emma H Wilson, Christopher A Hunter
Jun 15, 2004·Lancet·J G Montoya, O Liesenfeld
Dec 23, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·Thomas M BauerPeter Terness
Jul 12, 2005·Journal of Neuroimmunology·Emma H WilsonChristopher A Hunter
Jul 26, 2005·Infection and Immunity·Fangli LuLloyd H Kasper
Nov 7, 2006·Schizophrenia Bulletin·E Fuller TorreyRobert H Yolken
Jan 16, 2007·Schizophrenia Bulletin·Jaroslav Flegr
Apr 4, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ajai VyasRobert M Sapolsky
Apr 17, 2007·Schizophrenia Bulletin·Robert Schwarcz, Christopher A Hunter
Jul 29, 2009·European Journal of Immunology·Silvia K SchmidtWalter Däubener
Jan 29, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Brett C DiNataleGary H Perdew
Feb 4, 2010·The American Journal of Psychiatry·Alan S Brown, Elena J Derkits
Feb 12, 2010·Schizophrenia Bulletin·Ikwunga Wonodi, Robert Schwarcz
Aug 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joshua D MezrichChristopher A Bradfield
Nov 3, 2010·Schizophrenia Bulletin·Korrapati V SathyasaikumarRobert Schwarcz
Jan 5, 2012·Journal of Neural Transmission·Flavio MoroniGuido Mannaioni
Mar 27, 2012·Schizophrenia Bulletin·E Fuller TorreyRobert H Yolken
Apr 21, 2012·The European Journal of Neuroscience·Ana PocivavsekRobert Schwarcz
Jun 9, 2012·Nature Reviews. Neuroscience·Robert SchwarczHui-Qiu Wu
Jul 14, 2012·Parasitology Research·Ayse Basak EnginNeslihan Bukan
Sep 4, 2012·Schizophrenia Bulletin·Geetha Kannan, Mikhail V Pletnikov
Oct 2, 2012·Schizophrenia Research·Fernanda Santos NascimentoCláudio Lúcio Rossi
Nov 6, 2012·Trends in Pharmacological Sciences·Trevor W StoneL Gail Darlington

❮ Previous
Next ❯

Citations

Dec 23, 2015·Future Medicinal Chemistry·Francesco Antonio GrecoAntonio Macchiarulo
Nov 8, 2014·Parasite Immunology·Alexandru ParlogIldiko Rita Dunay
Aug 11, 2015·Acta Psychiatrica Scandinavica·L BrundinT T Postolache
Dec 4, 2014·Schizophrenia Research·Meng XiaMikhail Pletnikov
Jun 28, 2016·Neurotoxicity Research·J de BieG J Guillemin
Jul 14, 2016·Acta Neuropsychiatrica·Xi-Cong LiuAleksander A Mathé
Jul 10, 2016·Neuropharmacology·P J KennedyG Clarke
Nov 9, 2016·Translational Psychiatry·N Mechawar, J Savitz
Feb 7, 2017·Frontiers in Microbiology·Mahbobeh MontazeriAhmad Daryani
Oct 16, 2015·Antimicrobial Agents and Chemotherapy·Esther JortzikKatja Becker
Apr 28, 2016·Current Opinion in Infectious Diseases·Hany M Elsheikha, Xing-Quan Zhu
Jul 15, 2020·The Journal of Pharmacology and Experimental Therapeutics·Alexandros G Kokkosis, Stella E Tsirka
Nov 6, 2015·Frontiers in Neuroscience·Norbert MüllerMarkus J Schwarz
Apr 5, 2016·Metabolic Brain Disease·Hany M ElsheikhaXing-Quan Zhu
Apr 24, 2018·Frontiers in Molecular Biosciences·Anutthaman ParthasarathyAndré O Hudson
Oct 18, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ferenc ZádorLászló Vécsei
Dec 12, 2019·Advances in Nutrition·Kan GaoWei-Yun Zhu
Feb 14, 2017·Current Clinical Microbiology Reports·Anthony P SinaiAbhijit Patwardhan
Aug 12, 2018·Brain Sciences·Hugues LamotheLuc Mallet
Feb 23, 2018·Frontiers in Cellular and Infection Microbiology·Jing GaoYulong Yin
Jul 2, 2019·International Journal of Tryptophan Research : IJTR·Mona DehhaghiGilles J Guillemin
Jul 6, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lena BrundinKeerthi Thirtamara Rajamani
Nov 27, 2018·Neuroscience and Biobehavioral Reviews·Shiraz TyebjiChristopher J Tonkin
Nov 4, 2020·Annual Review of Animal Biosciences·Stefanie K Johnson, Pieter T J Johnson
Aug 9, 2020·Psychiatry Research·Amir Med KezaiSabrina Marion
Jun 29, 2021·Frontiers in Psychiatry·Teodor T PostolacheLisa A Brenner
Sep 4, 2021·Metabolic Brain Disease·Tooran NayeriAhmad Daryani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.